Skip to Content

Tuxarin ER Approval History

FDA Approved: Yes (First approved June 22, 2015)
Brand name: Tuxarin ER
Generic name: chlorpheniramine and codeine
Dosage form: Extended Release Tablets
Company: Spriaso LLC
Treatment for: Cough, Cold Symptoms

Tuxarin ER (codeine and chlorpheniramine) is a long acting narcotic antitussive and antihistamine combination for the treatment of cough and cold symptoms.

Development History and FDA Approval Process for Tuxarin ER

DateArticle
Jul  1, 2015Approval Spriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide